Success in developing targeted medicines means companies need a companion diagnostic strategy, the expertise, and more.
Barry S. Sall, Angela X. Qu, MD, PhD
Advertisement
Barry S. Sall is Principal Consultant, Parexel Consulting. Angela X. Qu, MD, PhD, is Senior Director â Biomarkers & Genomic Medicine, Parexel.
Articles by Barry S. Sall, Angela X. Qu, MD, PhD
Advertisement
Latest Updated Articles
Navigating the Complexities of Drug-Biomarker Co-DevelopmentPublished: October 1st 2018 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
2
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
3
Accelerating Development Through Parallel Execution and Rigorous Quality Controls
4
ACT Brief Weekly Recap: AI Innovation, Industry Resilience, and Supply Chain Readiness
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
